logowsbdaily | Mon, 27 Jun 2022 02:58:50 EST Where you find Tomorrow’s Hot Stocks Yesterday! 

NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.

TherapeuticsMD, Inc.
(TXMD)

TherapeuticsMD, Inc.
951 Yamato Road
Suite 220
Boca Raton, FL 33431
United States
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and pro... Read More

Summary & Charts

Price$ 9.97+0.04 (+0.4%)
Day's Range$ 9.85 - 9.97 
Previous Close$ 9.93
Market Cap$ 4.24B USD
Short Interest %N/A
FloatN/A
OutstandingN/A
ExchangeNasdaqGS
IndustryDrug Manufacturers—Specialty & Generic
SectorHealthcare
Volume877.18K
Avg. Volume (20 day)2.51M
Rel. Volume (20 day)0.35
Rel. Volume (3 month)0.14
RatingB+Neutral
DCFN/AStrong Buy
Debt/Equity-194.88 %Sell
ROE213.78 %Strong Buy
ROA-194.02 %Strong Sell
P/E-0.47 %Neutral
P/B-0.61 %Neutral
DateOpenHighLowCloseChangeVolumeR. Vol. (20d)R. Vol. (3m)Mentions
Jun 06, 2022$ 9.86$ 9.97$ 9.85$ 9.97+0.04877,1780.350.141
Jun 03, 2022$ 9.89$ 9.95$ 9.87$ 9.93-0.031,011,3550.330.16
Jun 02, 2022$ 9.89$ 9.96$ 9.83$ 9.96+0.021,791,8820.530.281
Jun 01, 2022$ 9.91$ 9.97$ 9.66$ 9.94+0.013,194,9110.840.481
May 31, 2022$ 9.54$ 9.99$ 9.12$ 9.93+7.797,439,0031.851.117
May 27, 2022$ 2.11$ 2.23$ 2.02$ 2.14+0.07599,2200.140.09
May 26, 2022$ 2.18$ 2.18$ 1.99$ 2.07-0.11584,3420.130.091
May 25, 2022$ 2.15$ 2.30$ 2.11$ 2.18+0.03578,0250.120.09
May 24, 2022$ 2.37$ 2.40$ 2.05$ 2.15-0.411,536,6510.300.23
May 23, 2022$ 3.00$ 3.05$ 2.50$ 2.56-0.541,708,6350.320.25
May 20, 2022$ 2.26$ 3.35$ 2.24$ 3.10+0.8322,108,6954.053.26
May 19, 2022$ 2.38$ 2.39$ 2.21$ 2.27-0.16432,8990.090.07
May 18, 2022$ 2.73$ 2.73$ 2.37$ 2.43-0.27554,7000.110.08
May 17, 2022$ 3.15$ 3.15$ 2.56$ 2.70-0.44879,5460.160.13
May 16, 2022$ 3.13$ 3.38$ 2.98$ 3.14+0.07766,8250.130.11
May 13, 2022$ 3.18$ 3.36$ 2.97$ 3.07+0.09791,2790.120.11
May 12, 2022$ 3.12$ 3.78$ 2.86$ 2.98-0.481,219,4490.190.17
May 11, 2022$ 4.15$ 4.64$ 3.45$ 3.46-1.141,131,1110.170.16
May 10, 2022$ 4.58$ 5.04$ 3.73$ 4.60-0.241,283,8530.180.18
May 09, 2022$ 6.55$ 6.55$ 4.11$ 4.84+4.691,689,3800.230.234

News

The latest news about TherapeuticsMD, Inc. (TXMD).

Pulse2 | 2022-05-31 14:47:23
TherapeuticsMD, Inc. (NASDAQ: TXMD) announced it entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners as part of a $177 million deal. These are the details.
Invezz | 2022-05-31 13:57:48
TherapeuticsMD Inc. (NASDAQ: TXMD) surged 300% after the women's healthcare firm announced the signing of a definitive agreement to be purchased by an EW Healthcare Partners affiliate. EW Healthcare Partners is a private equity company committed to investing in fast-growing healthcare firms.
Benzinga | 2022-05-31 10:12:04
TherapeuticsMD Inc (NASDAQ: TXMD) shares are surging Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners. EW Healthcare Partners will commence a tender offer to acquire all outstanding shares of.
PennyStocks | 2022-05-20 18:11:19
Are these biotech penny stocks on your watchlist right now? The post Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Benzinga | 2022-05-20 10:54:02
TherapeuticsMD Inc (NASDAQ: TXMD) shares are trading higher after FDA approved the supplemental application, including minor revisions to Annovera's in vitro release testing specification that allowed for normal manufacturing variability. The FDA approved Annovera in August.
Seeking Alpha | 2022-05-16 20:07:02
TherapeuticsMD, Inc. (NASDAQ:TXMD ) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Lisa Wilson - IR Hugh O'Dowd - CEO Michael Donegan - Interim CFO Mark Glickman - Chief Commercial Officer Conference Call Participants Operator Good afternoon, ladies and gentlemen. Thank you for joining us for Therapeutics MD's First Quarter 2020 Financial Results Conference Call.
Zacks Investment Research | 2022-05-16 18:48:09
TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -34.86% and 1.41%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Earnings

DateTimeEPS ExpectedEPS Reported%Revenue ExpectedRevenue Reported%
2022-05-16BMO-4-5.6942.25%------
2022-03-10BMO-0.08-0.1025%29M19M-35.55%
2021-11-11BMO-0.1-0.119.99%23M25M11.11%
2021-08-04BMO-0.11-0.11--23M23M--
2021-05-06BMO-0.12-0.118.34%22M20M-7.7%
2021-03-02BMO-0.1-0.1550%------
2020-11-09BMO-0.14-0.1214.29%22M19M-12.5%
2020-08-06BMO-0.17-0.1911.76%9.6M11M11.76%

Top Discussions

These are the top discussions over the last 24-hours that mention the TXMD stock ticker symbol.


Failures to Deliver

Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.

Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.

Last Updated: Mon, 13 Dec 2021 12:00 EST


Support & Feedback

Got feedback or suggestions for more awesomeness? Or wanna keep up to date with changes?

@wsbdaily@wsbdailywsbdaily subredditwsbdaily

No obligation, if you'd like to support us with development and hosting costs then

Buy Me A Coffee

Disclaimer

WE ARE NOT AFFILIATED WITH REDDIT, THE LEADERSHIP OR MODERATOR TEAMS OF ANY OF THE SUBREDDITS WE CRAWL NOR WITH ANY OTHER WEBSITE, COMPANY OR DATA PROVIDER FROM WHICH WE PULL AND/OR AGGREGATE DATA FROM.

ALL CONTENT ON THIS SITE IS SOLEY FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY. THE SITE AND CONTENT, ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. ANY CONTENT OR STATEMENT HEREIN SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, OR AS AN OFFER TO BUY, SELL, OR SOLICIT THE PURCHASE OR SALE OF ANY SECURITY OR FINANCIAL INSTRUMENT. DO YOUR OWN DUE DILIGENCE.

THE INFORMATION ON THIS SITE IS NOT UPDATED IN REAL-TIME, EACH DATASET SPECIFIES WHEN IT WAS “LAST UPDATED”. MOST INFORMATION IS CURRENTLY INDEPENDENTLY PERIODICALLY UPDATED EVERY 30 TO 150 MINUTES AND ONLY WHEN THE MARKETS ARE CLOSED. YOU BEAR ALL RISKS ASSOCIATED WITH THE USE OF THE SITE AND CONTENT, INCLUDING WITHOUT LIMITATION, ANY RELIANCE ON THE ACCURACY, COMPLETENESS OR USEFULNESS OF ANY CONTENT AVAILABLE ON THE SITE. YOUR USE OF THE INFORMATION CONTAINED HEREIN IS SOLELY AT YOUR OWN RISK. DO YOUR OWN DUE DILIGENCE.

There are high risks associated with investing in securities. Investing in stocks, options, bonds, ETFs, mutual funds, and money market funds involve risk of substantial loss. Loss of principal is possible. Some high risk investments may use leverage, which will greatly accentuate any losses. Foreign investing involves special risks, including a greater volatility and political, economic and currency risks and differences in accounting methods. Any past investment performance is not a guarantee or predictor of future investment performance. DO YOUR OWN DUE DILIGENCE.

The software providing the content on this site is currently in an alpha state. Although care is taken to publish accurate data inaccurate information is very, very possible. Use at your own risk. DO YOUR OWN DUE DILIGENCE.